Literature DB >> 27189933

Emerging role for regulated in development and DNA damage 1 (REDD1) in the regulation of skeletal muscle metabolism.

Bradley S Gordon1, Jennifer L Steiner2, David L Williamson3, Charles H Lang2, Scot R Kimball2.   

Abstract

Since its discovery, the protein regulated in development and DNA damage 1 (REDD1) has been implicated in the cellular response to various stressors. Most notably, its role as a repressor of signaling through the central metabolic regulator, the mechanistic target of rapamycin in complex 1 (mTORC1) has gained considerable attention. Not surprisingly, changes in REDD1 mRNA and protein have been observed in skeletal muscle under various physiological conditions (e.g., nutrient consumption and resistance exercise) and pathological conditions (e.g., sepsis, alcoholism, diabetes, obesity) suggesting a role for REDD1 in regulating mTORC1-dependent skeletal muscle protein metabolism. Our understanding of the causative role of REDD1 in skeletal muscle metabolism is increasing mostly due to the availability of genetically modified mice in which the REDD1 gene is disrupted. Results from such studies provide support for an important role for REDD1 in the regulation of mTORC1 as well as reveal unexplored functions of this protein in relation to other aspects of skeletal muscle metabolism. The goal of this work is to provide a comprehensive review of the role of REDD1 (and its paralog REDD2) in skeletal muscle during both physiological and pathological conditions.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  DDIT4; RTP801; dig2; muscle mass

Mesh:

Substances:

Year:  2016        PMID: 27189933      PMCID: PMC4967146          DOI: 10.1152/ajpendo.00059.2016

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  137 in total

Review 1.  Sexually dimorphic actions of glucocorticoids: beyond chromosomes and sex hormones.

Authors:  Matthew Quinn; Sivapriya Ramamoorthy; John A Cidlowski
Journal:  Ann N Y Acad Sci       Date:  2014-04-16       Impact factor: 5.691

2.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Richard Debigaré; Yves Lacasse; Pierre LeBlanc; Jean Jobin; Guy Carrier; François Maltais
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

3.  Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.

Authors:  Bronwyn A L Crawford; Peter Y Liu; Mary T Kean; Jane F Bleasel; David J Handelsman
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

4.  Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients.

Authors:  Cindy X Huang; Hocine Tighiouart; Srinivasan Beddhu; Alfred K Cheung; Johanna T Dwyer; Garabed Eknoyan; Gerald J Beck; Andrew S Levey; Mark J Sarnak
Journal:  Kidney Int       Date:  2010-01-13       Impact factor: 10.612

5.  Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes.

Authors:  Robert A Frost; Danuta Huber; Anne Pruznak; Charles H Lang
Journal:  J Cell Biochem       Date:  2009-12-01       Impact factor: 4.429

6.  Effects of physical exercise on the P38MAPK/REDD1/14-3-3 pathways in the myocardium of diet-induced obesity rats.

Authors:  B L S Pieri; D R Souza; T F Luciano; S O Marques; J R Pauli; A S R Silva; E R Ropelle; R A Pinho; F S Lira; C T De Souza
Journal:  Horm Metab Res       Date:  2014-04-01       Impact factor: 2.936

7.  The mTORC1 signaling repressors REDD1/2 are rapidly induced and activation of p70S6K1 by leucine is defective in skeletal muscle of an immobilized rat hindlimb.

Authors:  Andrew R Kelleher; Scot R Kimball; Michael D Dennis; Rudolf J Schilder; Leonard S Jefferson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-11-27       Impact factor: 4.310

8.  Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

Authors:  James Brugarolas; Kui Lei; Rebecca L Hurley; Brendan D Manning; Jan H Reiling; Ernst Hafen; Lee A Witters; Leif W Ellisen; William G Kaelin
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

9.  Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging.

Authors:  Noriko Oshiro; Joseph Rapley; Joseph Avruch
Journal:  J Biol Chem       Date:  2013-12-11       Impact factor: 5.157

10.  Excessive loss of skeletal muscle mass in older adults with type 2 diabetes.

Authors:  Seok Won Park; Bret H Goodpaster; Jung Sun Lee; Lewis H Kuller; Robert Boudreau; Nathalie de Rekeneire; Tamara B Harris; Stephen Kritchevsky; Frances A Tylavsky; Michael Nevitt; Yong-wook Cho; Anne B Newman
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 19.112

View more
  21 in total

1.  Loss of the glucocorticoid receptor in zebrafish improves muscle glucose availability and increases growth.

Authors:  Erin Faught; Mathilakath M Vijayan
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-04-02       Impact factor: 4.310

2.  Restorative Mechanisms Regulating Protein Balance in Skeletal Muscle During Recovery From Sepsis.

Authors:  Kristen T Crowell; David I Soybel; Charles H Lang
Journal:  Shock       Date:  2017-04       Impact factor: 3.454

3.  REDD1 induction regulates the skeletal muscle gene expression signature following acute aerobic exercise.

Authors:  Bradley S Gordon; Jennifer L Steiner; Michael L Rossetti; Shuxi Qiao; Leif W Ellisen; Subramaniam S Govindarajan; Alexey M Eroshkin; David L Williamson; Paul M Coen
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-09-12       Impact factor: 4.310

Review 4.  Epigenetic memory: gene writer, eraser and homocysteine.

Authors:  Suresh C Tyagi; Dragana Stanisic; Mahavir Singh
Journal:  Mol Cell Biochem       Date:  2020-10-08       Impact factor: 3.396

5.  Improved Risk Stratification in Pediatric Septic Shock Using Both Protein and mRNA Biomarkers. PERSEVERE-XP.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie C Fitzgerald; Paul A Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Shekhar S Raj; Shira Gertz; Jocelyn R Grunwell; Christopher J Lindsell
Journal:  Am J Respir Crit Care Med       Date:  2017-08-15       Impact factor: 21.405

Review 6.  Bone-Muscle Crosstalk: Musculoskeletal Complications of Chemotherapy.

Authors:  Brian A Hain; David L Waning
Journal:  Curr Osteoporos Rep       Date:  2022-09-10       Impact factor: 5.163

Review 7.  Interactions of the super complexes: When mTORC1 meets the proteasome.

Authors:  Olasunkanmi A J Adegoke; Brendan E Beatty; Scot R Kimball; Simon S Wing
Journal:  Int J Biochem Cell Biol       Date:  2019-10-31       Impact factor: 5.085

8.  Overexpression of DDIT4 and TPTEP1 are associated with metastasis and advanced stages in colorectal cancer patients: a study utilizing bioinformatics prediction and experimental validation.

Authors:  Fahimeh Fattahi; Jafar Kiani; Mahdi Alemrajabi; Ahmadreza Soroush; Marzieh Naseri; Mohammad Najafi; Zahra Madjd
Journal:  Cancer Cell Int       Date:  2021-06-09       Impact factor: 5.722

Review 9.  Amino acid homeostasis and signalling in mammalian cells and organisms.

Authors:  Stefan Bröer; Angelika Bröer
Journal:  Biochem J       Date:  2017-05-25       Impact factor: 3.857

10.  Female mice may have exacerbated catabolic signalling response compared to male mice during development and progression of disuse atrophy.

Authors:  Megan E Rosa-Caldwell; Seongkyun Lim; Wesley A Haynie; Jacob L Brown; John William Deaver; Francielly Morena Da Silva; Lisa T Jansen; David E Lee; Michael P Wiggs; Tyrone A Washington; Nicholas P Greene
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-03-05       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.